Predicting Ketamine Treatment Outcomes: Key Findings and Implications
The study "Predicting non-response to ketamine for depression: An exploratory symptom-level analysis of real-world data among...
The Comparative Effectiveness of Ketamine vs. Traditional Antidepressants: Personal Stories
Recent clinical studies have explored the effectiveness of ketamine compared to traditional antidepressants in treating depression. Research indicates...
The Resurgence of Psychedelic Psychiatry: An Exciting Yet Cautious Advance
In recent years, we've witnessed a remarkable revival in the field of psychedelic psychiatry and psychology. Several jurisdictions have decriminalized magic mushrooms, and...
Advancing Treatment Approaches for Treatment-Resistant Depression
Treatment-resistant depression (TRD) is a complex challenge in mental health, characterized by patients' inadequate response to standard antidepressant therapies. The landmark ...
OCD in the Shadow of Depression
Diagnosing Obsessive-Compulsive Disorder (OCD) can take years before individuals receive an accurate diagnosis. The average delay in diagnosis is 6 to 10 years...
How Ketamine and CBT Work Together to Combat Depression
Ketamine can rapidly alleviate depressive symptoms, often within hours, compared to the weeks or months typically required for traditional antidepressants to...
Unlocking the Brain: How the Lateral Habenula Influences Depression and Ketamine Therapy
In the intricate landscape of neuroscience, the lateral habenula (LHb) stands out as a critical structure in understanding depression. This blog explores...
Ketamine and the Future of Mental Health: Insights from the Oxford International Conference
The Oxford Ketamine International Conference in March 2024 brought together leading experts and researchers from around the world to explore the basic science and...
Even More on Brain Zaps
People outside the mainstream medical establishment continue to show interest in the phenomenon of brain zaps, while academia remains ...
The Risks of Take-Home Ketamine: A Cautionary Perspective
Ketamine, an NMDA receptor antagonist, has shown promise in the treatment of various psychiatric disorders, including depression and PTSD. Its rapid-acting...
- 1
- 2
- 3
- 4
- 5
- Go to the next page